arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Nexalin Technology, Inc.

NXL

$0.36 ▲ +0.02 (+4.66%) at close

6 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Nexalin Technology, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.9M

Dividend Yield —

Revenue Growth 78.8% ↗

Op. Margin None

ROIC -176.9% ↘

FCF / Share $-0.30 ↗

Trailing P/E —

Price / Book 1.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$301.65K

↑ +78.8% —

Net Income Profit after all expenses

$-8.22M

↓ -8.1% —

FCF / Share Free cash flow per share

$-0.30

↑ +29.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	78.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+885%)	52.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+554%)	-91.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1245%)	817.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10115%)	—	—
EPS Growth YoY (%)	39.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-31.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-110.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	-8.1% Weak ↑ Weak Improving Year-over-year change in net income	-63.6% Weak ↓ Weak Declining Year-over-year change in net income	-173.8% Weak Weak Year-over-year change in net income	72.1% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	29.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	17.9% Good Good Year-over-year change in free cash flow	-31.1% Weak Weak Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	-38.9% Weak Weak Compound annual revenue growth over 3 years	5.4% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	—	—	—	-138.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1025%)	—	—
Profit Margin (%) (%)	—	—	—	-128.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1171%)	—	—
FCF Margin (%) (%)	—	—	—	-167.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.31x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-176.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-166.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-140.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	282.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-181.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-183.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-156.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-798.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-219.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1563%)	-206.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1480%)	-145.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1066%)	-31.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-307%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	-1018.31x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2428.64x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-146.68x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-30.87x Weak Weak Operating income divided by interest expense Optimal: > 5x	-73.11x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-654.78K	$-574.49K	$-580.23K	$-162.74K	$-661.78K	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$0.02	$0.02	$0.02	$0.24	—	—
Basic EPS, GAAP (USD)	$-0.50	$-0.83	$-0.63	$-0.30	—	—
Free Cash Flow per Share (USD)	$-0.30	$-0.43	$-0.52	$-0.40	—	—
Book Value per Share (USD)	$0.20	$0.28	$0.43	$0.75	$-0.34	—
Tangible Book Value per Share (USD)	$0.18	$0.26	$0.42	$0.75	$-0.34	—
Basic Weighted Avg Shares (shares)	16.39M	9.22M	7.36M	5.57M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$3.41M	$3.41M	$3.00M	$5.48M	$-1.61M	—
Total Equity (USD)	$3.75M	$3.68M	$3.21M	$5.48M	$-1.68M	$-1.59M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$301.65K	$168.72K	$110.75K	$1.32M	$144.06K	—
Depreciation Expense (USD)	—	—	$503.00	$535.00	$537.00	—
Net Income, GAAP (USD)	$-8.22M	$-7.61M	$-4.65M	$-1.70M	$-6.08M	—
Operating Cash Flow (USD)	$-4.96M	$-3.94M	$-3.84M	$-2.22M	$-1.08M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

Nexalin Technology, Inc.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NXL with peers